• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA Clears Radiology AI Enterprise Imaging Platform from CARPL.ai


Offering access to over 110 AI applications, the enterprise imaging platform enables radiologists to test, deploy and monitor the use of AI technologies.

The Food and Drug Administration (FDA) has granted 510(k) clearance for the CARPL.ai enterprise imaging artificial intelligence (AI) platform, a development that may help streamline the adoption of AI into radiology workflows.

CARPL.ai noted the platform allows radiologists access to over 110 AI applications from over 50 vendors with a single user interface. The platform facilitates worklist triage, segmentation, clinical audits, and auto-populated reports, according to the company.

Noting the adaptable capability of the platform for on-site or cloud-based hosting, CARPL.ai emphasized the potential for rapid scaling with no incremental costs for piloting of AI applications.

Vijay Rao, M.D., FACR, a senior vice president of enterprise radiology and imaging ay Jefferson Health in Philadelphia, added that the FDA clearance of the CARPL.ai platform allows for PACS integration of FDA-cleared AI applications that don’t have separate FDA-cleared viewers.

“This FDA clearance opens the door for widespread adoption of AI solutions through a platform approach which simplifies the process of selection, implementation, and procurement of AI by health systems,” noted Vidur Mahajan, the chief executive officer at CARPL.ai.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.